m102.4

N/A

Report date: 2024/04/24 14:47:19

Base Information

Drug Namem102.4
Drug Alias NameAntiviral monoclonal antibody (Profectus BioSciences)Hendra virus monoclonal antibody (Profectus BioSciences)Nipah virus monoclonal antibody (Profectus BioSciences)m102.4-mAbm102.4
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionEphrin receptor modulators
TargetsEphrin receptor
Therapy Area/IndicationsHenipavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAuro Vaccines LlcNational Cancer InstituteUniformed Services University Of The Health Sciences
China Registration ClassN/A

Develop Information

Active CompaniesDivision Of Microbiology And Infectious Diseases (Dmid)Queensland Department of HealthMapp Biopharmaceutical Inc +[4] 
Inactive CompaniesN/A
Active IndicationsHenipavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A